References
Zuger A: Fever pitch: getting doctors to prescribe is big business. New York Times, 1999
Drake D, Uhlman M: Making Medicine, Making Money. Kansas City, Andrews and McMeel, 1993
Chren MM, Landefeld CS: Physicians’ behavior and their interactions with drug companies: a controlled study of physicians who requested additions to a hospital drug formulary. JAMA 1994; 271: 684–689
Bowman MA, Pearle DL: Changes in drug prescribing patterns related to commercial company funding of continuing medical education. J Contin Educ Health Prof 1988; 8: 13–20
Steinman MA, Shlipak MG, McPhee SJ: Of principles and pens: attitudes and practices of medicine housestaff toward pharmaceutical industry promotions. Am J Med 2001; 110: 551–557
Lurie N, Rich EC, Simpson DE, et al: Pharmaceutical representatives in academic medical centers: interaction with faculty and housestaff. J Gen Intern Med 1990; 5: 240–243
Kowalczyk L: Massachusetts General moves to curb drugven-dors. Boston Globe, 2002
McCormick BB, Tomlinson G, Brill-Edwards P, et al: Effect of restricting contact between pharmaceutical company representatives and internal medicine residents on posttraining attitudes and behavior. JAMA 2001; 286: 1994–1999
Steiner JL, Norko M, Devine S, et al: Developing ethical guidelines for pharmaceutical company support in an academic mental health center. Psychiatr Serv 2003; 54: 1079–1089
Author information
Authors and Affiliations
Additional information
An erratum to this article is available at http://dx.doi.org/10.1007/BF03339774.
Rights and permissions
About this article
Cite this article
Huang, F.Y., Weiss, D.S., Fenimore, P.G. et al. The Association of Pharmaceutical Company Promotional Spending With Resident Physician Prescribing Behavior. Acad Psychiatry 29, 500–501 (2005). https://doi.org/10.1176/appi.ap.29.5.500
Published:
Issue Date:
DOI: https://doi.org/10.1176/appi.ap.29.5.500